Could a simple urine sample help detect bladder cancer without immediately putting patients through invasive tests? Researchers are exploring this possibility with a new technique that analyses tiny genetic molecules in urine to identify signs of cancer.
A proof-of-concept study published in Nature Medicine on October 2, 2026, found that the test could detect 95 per cent of bladder cancer cases among the samples studied, including those at an early stage. The researchers analysed samples from 515 cancer patients and healthy individuals.
Unlike conventional liquid biopsy tests that largely look for DNA released by tumours into the blood, this technique focuses on RNA, a molecule that carries information about which genes are switched on and how cells are functioning.
The findings are particularly interesting because urine comes into direct contact with the bladder.…